Cargando…

Electrocardiographic substrates of arrhythmias in patients with end-stage and chronic kidney diseases: a case–control study

BACKGROUND: Cardiovascular disease (CVD) is the most common cause of death in patients with renal diseases. Cardiac arrhythmia and sudden cardiac death are particularly important, and the burden is higher in patients on hemodialysis. The aim of this study is to compare specific ECG changes as marker...

Descripción completa

Detalles Bibliográficos
Autores principales: Yehia, Hesham, Youssef, Ghada, Gamil, Mona, Elsaeed, Mahmoud, Sadek, Khaled M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9943799/
https://www.ncbi.nlm.nih.gov/pubmed/36802307
http://dx.doi.org/10.1186/s43044-023-00338-5
_version_ 1784891781828050944
author Yehia, Hesham
Youssef, Ghada
Gamil, Mona
Elsaeed, Mahmoud
Sadek, Khaled M.
author_facet Yehia, Hesham
Youssef, Ghada
Gamil, Mona
Elsaeed, Mahmoud
Sadek, Khaled M.
author_sort Yehia, Hesham
collection PubMed
description BACKGROUND: Cardiovascular disease (CVD) is the most common cause of death in patients with renal diseases. Cardiac arrhythmia and sudden cardiac death are particularly important, and the burden is higher in patients on hemodialysis. The aim of this study is to compare specific ECG changes as markers of arrhythmias in patients with CKD and patients with end-stage renal disease (ESRD); all without clinically manifest heart disease, with normal control subjects. RESULTS: Seventy-five ESRD patients on regular hemodialysis, 75 patients with stage 3–5 CKD and 40 healthy control subjects were included. All candidates were subjected to thorough clinical evaluation and laboratory tests including serum creatinine, glomerular filtration rate calculation, serum potassium, magnesium, calcium, phosphorus, iron, parathyroid hormone, and total iron binding capacity (TIBC). Resting twelve-lead ECG was done to calculate P wave dispersion (P-WD), corrected QT interval, QTc dispersion, Tpeak-Tend interval (Tp-e), and Tp-e/QT. Patients with ESRD had a significantly higher QTc dispersion (p < 0.001) and P-WD (p = 0.001) when compared to the other 2 groups. In the ESRD group, males had a significantly higher P-WD (p = 0.045), insignificantly higher QTc dispersion (p = 0.445), and insignificantly lower Tp-e/QT ratio (p = 0.252) as compared to females. Multivariate linear regression analysis for ESRD patients showed that serum creatinine (β = 0.279, p = 0.012) and transferrin saturation (β =  − 0.333, p = 0.003) were independent predictors of increased QTc dispersion while ejection fraction (β = 0.320, p = 0.002), hypertension (β =  − 0.319, p = 0.002), hemoglobin level (β =  − 0.345, p = 0.001), male gender (β =  − 0.274, p = 0.009) and TIBC (β =  − 0.220, p = 0.030) were independent predictors of increased P wave dispersion. In the CKD group, TIBC (β =  − 0.285, p = 0.013) was an independent predictor of QTc dispersion while serum calcium (β = 0.320, p = 0.002) and male gender (β =  − 0.274, p = 0.009) were independent predictors of Tp-e/QT ratio. CONCLUSIONS: Patients with stage 3–5 CKD and those with ESRD on regular hemodialysis exhibit significant ECG changes that are considered substrates for ventricular as well as supraventricular arrhythmias. Those changes were more evident in patients on hemodialysis.
format Online
Article
Text
id pubmed-9943799
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-99437992023-02-23 Electrocardiographic substrates of arrhythmias in patients with end-stage and chronic kidney diseases: a case–control study Yehia, Hesham Youssef, Ghada Gamil, Mona Elsaeed, Mahmoud Sadek, Khaled M. Egypt Heart J Research BACKGROUND: Cardiovascular disease (CVD) is the most common cause of death in patients with renal diseases. Cardiac arrhythmia and sudden cardiac death are particularly important, and the burden is higher in patients on hemodialysis. The aim of this study is to compare specific ECG changes as markers of arrhythmias in patients with CKD and patients with end-stage renal disease (ESRD); all without clinically manifest heart disease, with normal control subjects. RESULTS: Seventy-five ESRD patients on regular hemodialysis, 75 patients with stage 3–5 CKD and 40 healthy control subjects were included. All candidates were subjected to thorough clinical evaluation and laboratory tests including serum creatinine, glomerular filtration rate calculation, serum potassium, magnesium, calcium, phosphorus, iron, parathyroid hormone, and total iron binding capacity (TIBC). Resting twelve-lead ECG was done to calculate P wave dispersion (P-WD), corrected QT interval, QTc dispersion, Tpeak-Tend interval (Tp-e), and Tp-e/QT. Patients with ESRD had a significantly higher QTc dispersion (p < 0.001) and P-WD (p = 0.001) when compared to the other 2 groups. In the ESRD group, males had a significantly higher P-WD (p = 0.045), insignificantly higher QTc dispersion (p = 0.445), and insignificantly lower Tp-e/QT ratio (p = 0.252) as compared to females. Multivariate linear regression analysis for ESRD patients showed that serum creatinine (β = 0.279, p = 0.012) and transferrin saturation (β =  − 0.333, p = 0.003) were independent predictors of increased QTc dispersion while ejection fraction (β = 0.320, p = 0.002), hypertension (β =  − 0.319, p = 0.002), hemoglobin level (β =  − 0.345, p = 0.001), male gender (β =  − 0.274, p = 0.009) and TIBC (β =  − 0.220, p = 0.030) were independent predictors of increased P wave dispersion. In the CKD group, TIBC (β =  − 0.285, p = 0.013) was an independent predictor of QTc dispersion while serum calcium (β = 0.320, p = 0.002) and male gender (β =  − 0.274, p = 0.009) were independent predictors of Tp-e/QT ratio. CONCLUSIONS: Patients with stage 3–5 CKD and those with ESRD on regular hemodialysis exhibit significant ECG changes that are considered substrates for ventricular as well as supraventricular arrhythmias. Those changes were more evident in patients on hemodialysis. Springer Berlin Heidelberg 2023-02-21 /pmc/articles/PMC9943799/ /pubmed/36802307 http://dx.doi.org/10.1186/s43044-023-00338-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Yehia, Hesham
Youssef, Ghada
Gamil, Mona
Elsaeed, Mahmoud
Sadek, Khaled M.
Electrocardiographic substrates of arrhythmias in patients with end-stage and chronic kidney diseases: a case–control study
title Electrocardiographic substrates of arrhythmias in patients with end-stage and chronic kidney diseases: a case–control study
title_full Electrocardiographic substrates of arrhythmias in patients with end-stage and chronic kidney diseases: a case–control study
title_fullStr Electrocardiographic substrates of arrhythmias in patients with end-stage and chronic kidney diseases: a case–control study
title_full_unstemmed Electrocardiographic substrates of arrhythmias in patients with end-stage and chronic kidney diseases: a case–control study
title_short Electrocardiographic substrates of arrhythmias in patients with end-stage and chronic kidney diseases: a case–control study
title_sort electrocardiographic substrates of arrhythmias in patients with end-stage and chronic kidney diseases: a case–control study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9943799/
https://www.ncbi.nlm.nih.gov/pubmed/36802307
http://dx.doi.org/10.1186/s43044-023-00338-5
work_keys_str_mv AT yehiahesham electrocardiographicsubstratesofarrhythmiasinpatientswithendstageandchronickidneydiseasesacasecontrolstudy
AT youssefghada electrocardiographicsubstratesofarrhythmiasinpatientswithendstageandchronickidneydiseasesacasecontrolstudy
AT gamilmona electrocardiographicsubstratesofarrhythmiasinpatientswithendstageandchronickidneydiseasesacasecontrolstudy
AT elsaeedmahmoud electrocardiographicsubstratesofarrhythmiasinpatientswithendstageandchronickidneydiseasesacasecontrolstudy
AT sadekkhaledm electrocardiographicsubstratesofarrhythmiasinpatientswithendstageandchronickidneydiseasesacasecontrolstudy